Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.81 USD
Change Today +0.69 / 3.27%
Volume 2.7M
HZNP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. De Vaere

Consultant, Horizon Pharma plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

56$908,897
As of Fiscal Year 2013

Background*

Mr. Robert J. De Vaere, also known as Bob, has been Consultant of Horizon Pharma plc since October 1, 2014. Mr. De Vaere served as Chief Financial Officer and Executive Vice President of Horizon Pharma plc from March 2010 to September 30, 2014 and also as its Principal Accounting Officer and Secretary until September 30, 2014. Mr. De Vaere has served as an Executive Vice President and Chief Financial Officer of Horizon Pharma USA, Inc. from October 2008 to September ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, -- 4

Ireland

Phone: 353 1 772 2100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

Salary$374,920
Total Annual Compensation$374,920

Stock Options*

Restricted Stock Awards$256,667
All Other Compensation$600
Exercisable Options167,508
Exercisable Options Value$242,837
Unexercisable Options73,397
Unexercisable Options Value$281,337
Total Value of Options$524,174
Total Number of Options240,905

Total Compensation*

Total Annual Cash Compensation$562,980
Total Short Term Compensation$374,920
Other Long Term Compensation$257,267
Total Calculated Compensation$908,897
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HZNP:US $21.81 USD +0.69

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HORIZON PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.